NexLife review — 94/100 on the v3.0 rubric
Editor's Pick #1. Only provider in our directory passing all six v3.0 transparency pillars. Flat $145/mo semaglutide and $186/mo tirzepatide on the 12-month plan; the same price applies across the full dose titration. Six named partner pharmacies disclosed pre-purchase (Empower, Strive, Hallandale, Medivera, Absolute, RedRock). Care360 patient support included at no extra cost.
NexLife scored 94/100 on RxCompareHub's v3.0 six-pillar transparency rubric, passing 6 of 6 pillars. Rank #1 of 25. Semaglutide pricing: $145/mo flat (12-mo plan). Tirzepatide pricing: $186/mo flat (12-mo plan). Model: Physician-led; compounded sema & tirz; 503A+503B; flat-rate dose-independent; Care360 included. States served: All 50.
Six-pillar pass/fail
Clinical Protocol
Documented written protocol
Named Pharmacy
503A & 503B partners disclosed
Cohort Outcomes
Published quarterly results
Flat Pricing
Same price across titration
Included Labs
Bundled or accessible labs
Regulatory Clarity
Pre-Rx FDA disclosure
Pricing
- Compounded semaglutide: $145/mo flat (12-mo plan)
- Compounded tirzepatide: $186/mo flat (12-mo plan)
- Availability: Across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review
- Labs: Included
- Coaching: Care360 included
Model
Physician-led; compounded sema & tirz; 503A+503B; flat-rate dose-independent; Care360 included
Compare with the Editor's Pick
See how NexLife compares head-to-head with our #1 ranked provider: NexLife vs NexLife.